Krystal Biotech doses first subject in lung cancer drug trial
US-based biotechnology company Krystal Biotech has dosed the first subject in the Phase I KYANITE-1 clinical trial for its inhaled…
US-based biotechnology company Krystal Biotech has dosed the first subject in the Phase I KYANITE-1 clinical trial for its inhaled…
Singapore-based biopharmaceutical company ASLAN Pharmaceuticals has announced positive interim data from its Phase II TREK-DX study of eblasakimab, a drug…
Australian biotechnology company Actinogen Medical has finished enrolling subjects in the Phase IIa XanaCIDD clinical trial of Xanamem for treating…
US-based biopharmaceutical company Lantern Pharma has received regulatory approval for expanding its Phase II Harmonic clinical trial of an investigational…
D2M Biotherapeutics has dosed the first subject in a Phase I clinical trial of DM919 for the potential treatment of…
The Philippine Food and Drug Administration (PFDA) has granted clinical trial approval for YS Biopharma's YS-HBV-002, an immunotherapeutic vaccine aimed…
AbbVie has revealed positive top-line outcomes from the first period of the Phase III SELECT-GCA study of upadacitinib (RINVOQ; 15mg,…
Cerevel Therapeutics has reported positive topline results from its Phase III TEMPO-3 clinical trial evaluating a once-a-day dose of tavapadon…
Artiva Biotherapeutics has announced dosing of the first subject in the Phase I clinical trial of AlloNK (AB-101), a natural…
Roche has reported data from the Phase III OCARINA II study of a subcutaneous (SC) injection of OCREVUS (ocrelizumab) in…